These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11245297)

  • 1. Therapy and drug resistance in Helicobacter pylori infection.
    Bazzoli F; Olivieri L; De Luca L; Pozzato P; Lehours P; Mégraud F
    Dig Liver Dis; 2000 Dec; 32 Suppl 3():S207-10. PubMed ID: 11245297
    [No Abstract]   [Full Text] [Related]  

  • 2. Clarithromycin resistance in Helicobacter pylori infection: does it matter?
    Fock KM
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1089-92. PubMed ID: 11106085
    [No Abstract]   [Full Text] [Related]  

  • 3. Helicobacter pylori infection and antibiotic resistance: a WHO high priority?
    Dang BN; Graham DY
    Nat Rev Gastroenterol Hepatol; 2017 Jul; 14(7):383-384. PubMed ID: 28465548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clarithromycin resistance in Helicobacter pylori: implications for therapy.
    Fujioka T
    J Gastroenterol; 2000; 35(1):69-70. PubMed ID: 10632546
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment failures and secondary resistance to antibiotics. A growing concern in Helicobacter pylori therapy.
    de Boer WA; Borody TJ
    Dig Liver Dis; 2000 Nov; 32(8):673-5. PubMed ID: 11142575
    [No Abstract]   [Full Text] [Related]  

  • 6. [Established eradication therapy fails. What will eliminate Helicobacter now?].
    Bischoff A
    MMW Fortschr Med; 2009 Sep; 151(39):18. PubMed ID: 19831188
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
    Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
    Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs for Helicobacter pylori infection.
    Med Lett Drugs Ther; 2017 Jul; 59(1525):113-117. PubMed ID: 28699931
    [No Abstract]   [Full Text] [Related]  

  • 9. [Eradication therapy for Helicobacter pylori infection: review of world trends].
    Maev IV; Kucheriavyĭ IuA; Andreev DN; Barkalova EV
    Ter Arkh; 2014; 86(3):94-9. PubMed ID: 24779078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Helicobacter pylori infection.
    Fuccio L; Laterza L; Zagari RM; Cennamo V; Grilli D; Bazzoli F
    BMJ; 2008 Sep; 337():a1454. PubMed ID: 18794181
    [No Abstract]   [Full Text] [Related]  

  • 11. Strategies to treat patients with antibiotic resistant Helicobacter pylori.
    Mégraud F
    Int J Antimicrob Agents; 2000 Dec; 16(4):507-9. PubMed ID: 11118869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of resistance to antimicrobial agents of H. pylori].
    Raymond J; Kalach N; Lamarque D; Burucoa C
    Arch Pediatr; 2010 Jun; 17(6):816-7. PubMed ID: 20654908
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical relevance of resistant strains of Helicobacter pylori: a review of current data.
    Mégraud F; Doermann HP
    Gut; 1998 Jul; 43 Suppl 1(Suppl 1):S61-5. PubMed ID: 9764043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.
    Tanabe H; Yoshino K; Ando K; Nomura Y; Ohta K; Satoh K; Ichiishi E; Ishizuka A; Otake T; Kohgo Y; Fujiya M; Okumura T
    Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):29. PubMed ID: 29950163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Helicobacter pylori infection: Where are we now?
    Liou JM; Wu MS; Lin JT
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1918-1926. PubMed ID: 27088632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin.
    Furuta T; Shirai N; Xiao F; Takashita M; Sugimoto M; Kajimura M; Ohashi K; Ishizaki T
    Hepatogastroenterology; 2003; 50(54):2274-8. PubMed ID: 14696516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [RESISTANCE OF HELICOBACTER PYLORI TO ANTIBIOTICS IN ISRAEL: PAST VS PRESENT].
    Peretz A; Paritsky M; Brodsky D; Pastukh N; On A
    Harefuah; 2017 Oct; 156(10):642-644. PubMed ID: 29072383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance mechanisms of Helicobacter pylori.
    Hoffman PS
    Can J Gastroenterol; 1999 Apr; 13(3):243-9. PubMed ID: 10331936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea.
    Hwang TJ; Kim N; Kim HB; Lee BH; Nam RH; Park JH; Lee MK; Park YS; Lee DH; Jung HC; Song IS
    J Clin Gastroenterol; 2010 Sep; 44(8):536-43. PubMed ID: 20179610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failed Eradication for Helicobacter pylori. What Should Be Done?
    Mégraud F
    Dig Dis; 2016; 34(5):505-9. PubMed ID: 27332826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.